PBAC Public Summary Documents – July 2020

Page last updated: 13 November 2020

Public Summary Documents relating to the July 2020 PBAC meeting.

• Acalabrutinib: Capsule 100 mg; Calquence®
• Adalimumab: Injection 40 mg in 0.8 mL pre-filled syringe, Injection 40 mg in 0.8 mL single dose autoinjector; Hadlima®
• Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine, supplemented with docosahexaenoic acid: Sachets containing oral powder 33 g, 30; PKU Synergy®
• Amino acid formula with vitamins and minerals without methionine: Sachets containing oral powder 28 g, 30; HCU Lophlex®
• Amino acid formula with vitamins and minerals without phenylalanine and tyrosine: Sachets containing oral powder 28 g, 30; TYR Lophlex®
• Amino acid formula with vitamins and minerals without valine, leucine and isoleucine: Sachets containing oral powder 28 g, 30; MSUD Lophlex®
• Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine, 2. Amino acid formula with vitamins and minerals without phenylalanine and tyrosine, 3. Amino acid formula with vitamins and minerals without lysine and low in tryptophan, 4. Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine, 5. Amino acid formula with vitamins and minerals without methionine, 6. Amino acid formula with vitamins and minerals without valine, leucine and isoleucine: Oral powder 400 g; 1. PKU Anamix Infant®, 2. TYR Anamix Infant®, 3. GA1 Anamix Infant®, 4. MMA/PA Anamix Infant®, 5. HCU Anamix Infant®, 6. MSUD Anamix Infant®
• Apremilast: Tablet 30 mg, Pack containing 4 tablets of 10 mg, 4 tablets of 20 mg and 19 tablets of 30 mg; Otezla®
• Armodafinil and Modafinil: modafinil: Tablet 100 mg; armodafinil: Tablet 50 mg, Tablet 150 mg, Tablet 250 mg; Various brands - July 2020
• Atezolizumab and Bevacizumab: atezolizumab: Solution concentrate for I.V. infusion 1200 mg in 20 mL, Solution concentrate for I.V. infusion 840 mg in 14 mL; bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Tecentriq® and Avastin®
• Beclometasone dipropionate with Formoterol fumarate dihydrate: Powder for oral inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses; Fostair®
• Belimumab: Injection 200 mg in 1 mL pre-filled pen; Benlysta®
• Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V infusion 400 mg in 16 mL; Zirabev®
• Bimatoprost: 300 micrograms per mL, 3 mL; Vizo-PF Bimatoprost®
• Biologics for the treatment of chronic plaque psoriasis: Cost-effectiveness review
• Brolucizumab: Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe; Beovu®
• Cannabidiol: Oral solution, 100 mg per mL, 100 mL; Epidyolex®
• Caplacizumab: Injection set containing 1 vial powder for injection 10 mg and 1 pre-filled syringe solvent 1 mL; Cablivi® - July 2020
• Carbohydrate, fat, vitamins, minerals and trace elements: Oral powder 400 g; Energivit®
• Carfilzomib: Powder for injection 10 mg, Powder for injection 30 mg, Powder for injection 60 mg; Kyprolis®
• Cationic ophthalmic emulsion, preservative free: Eye drops containing heavy mineral oil 0.5% and light mineral oil 0.5%, 10 mL; Cationorm®
• Clostridium botulinum type A toxin-haemagglutinin complex: Lyophilised powder for I.M. injection 300 units, Lyophilised powder for I.M. injection 500 units; Dysport®
• Daratumumab: 100 mg/5 mL injection, 5 mL vial, 400 mg/20 mL injection, 20 mL vial; Darzalex®
• Darolutamide: Tablet 300 mg; Nubeqa® - July 2020
• Dolutegravir with Lamivudine: Tablet containing dolutegravir 50 mg (as sodium) with lamivudine 300 mg; Dovato®
• Dulaglutide: Injection 1.5 mg in 0.5 mL single dose pre-filled pen; Trulicity®
• Enoxaparin: Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe, Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL syringe, Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL syringe, Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe, Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe, Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe, Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL syringe; Enoxapo®
• Fosnetupitant (as chloride hydrochloride)/ palonosetron (as hydrochloride): Powder for Injection containing fosnetupitant 235 mg and palonosetron 250 mg; Akynzeo IV®
• Fulvestrant: Injection 250 mg in 5 mL pre-filled syringe; Faslodex®
• Glycomacropeptide and essential amino acids with vitamins and minerals: Sachets containing oral powder 31 g, 30; Tylactin Build 20®
• Guselkumab: Solution for injection 100 mg in 1 mL pen device; Tremfya®
• Indacaterol with Mometasone: Capsule containing powder for oral inhalation mometasone furoate 80 micrograms  with indacaterol 150 micrograms (as acetate) (for use in Breezhaler®), Capsule containing powder for oral inhalation mometasone furoate 160 micrograms with indacaterol 150 micrograms (as acetate) (for use in Breezhaler®), Capsule containing powder for oral inhalation mometasone furoate 320 micrograms with indacaterol 150 micrograms (as acetate) (for use in Breezhaler®); Atectura Breezhaler®
• Indacaterol with Glycopyrronium and Mometasone: Capsule containing powder for oral inhalation mometasone furoate 80 micrograms with indacaterol 150 micrograms (as acetate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler), Capsule containing powder for oral inhalation mometasone furoate 160 micrograms  with indacaterol 150 micrograms (as acetate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler); Enerzair Breezhaler® - July 2020
• Ixekizumab: Injection 80 mg in 1 mL single dose pre-filled pen; Taltz®
• Lanadelumab: Solution for subcutaneous injection 300 mg in 2 mL; Takhzyro® - July 2020
• Milk powder synthetic low calcium: Low calcium oral powder 400 g; Locasol®
• Mogamulizumab; Solution concentrate for I.V. infusion 20 mg in 5 mL; Poteligeo®
• Nusinersen: Solution for injection 12 mg in 5 mL; Spinraza®
• Ocrelizumab: Solution concentrate for I.V. infusion 300 mg in 10 mL; Ocrevus®
• Olaparib: Tablet 100 mg, Tablet 150 mg: Lynparza®
• Osimertinib: Tablet 40 mg, Tablet 80 mg; Tagrisso®
• Paracetamol: Suppositories 500 mg, 24; Panadol®
• Protein formula  with vitamins and minerals, low in potassium, phosphorus, calcium, chloride and vitamin A: Oral liquid 125 mL, 24; Renastep®
• Quadrivalent influenza vaccine, split virion, inactivated: Injection 0.5 mL; Fluarix Tetra®
• Ravulizumab: Solution concentrate for I.V. infusion 300 mg in 30 mL; Ultomiris®
• Ribociclib: Tablet 200 mg; Kisqali® - July 2020
• Rifampicim: Capsule 150 mg, Capsule 300 mg; Rimycin 150®, Rymicin 300® - July 2020
• Rivaroxaban: Tablet 2.5 mg; Xarelto®
• Selexipag: Tablet 200 microgram, Tablet 400 microgram, Tablet 600 microgram, Tablet 800 microgram, Tablet 1 mg, Tablet 1.2 mg, Tablet 1.4 mg, Tablet 1.6 mg; Uptravi®
• Siponimod: Tablet 250 micrograms, Tablet 2 mg; Mayzent®
• Tafamidis: Capsule 61 mg; Vyndamax® - July 2020
• Terbutaline: Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 120 doses; Bricanyl® Turbuhaler®
• Tiotropium: Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations); Sprivia® Respimat®
• Tiotropium with Olodaterol: Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses; Spiolto® Respimat®
• Topotecan: Solution concentrate for I.V. infusion 4 mg in 4 mL (as hydrochloride); Topotecan Accord®
• Triglycerides medium chain formula: Oral powder 400 g; Monogen®
• Venetoclax: Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14 tablets venetoclax 100 mg, Tablet 10 mg, Tablet 50 mg, Tablet 100 mg; Venclexta®
• Vitamins, minerals and trace elements with carbohydrate: Oral powder 200 g; Paediatric Seravit®
• Whey protein formula supplemented with amino acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose: Oral powder 400 g; Kindergen®